Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta and Tarceva in advanced solid tumors and NSCLC
NCT00387322Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Mar 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pemetrexed and erlotinib in solid tumor (advanced stage) and non-small cell lung cancer (NSCLC), sponsored by University of California, Davis. Started Mar 2005; status: completed.
02
Drugs
pemetrexederlotinib
03
Conditions
solid tumor (advanced stage)non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00387322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387322.